Positive SI | Before Matching n = 406 | After Matching n = 337 | ||||
---|---|---|---|---|---|---|
PS covariate | Cases | Controls | p value (d*) | Cases | Controls | p value (d*) |
n = 157 | n = 249 | n = 97 | n = 240 | 0.01 | ||
Age | 68 ± 16 | 70 ± 15 | 0.24 | 72 ± 14 | 67 ± 16 | 0.92 |
Hypertension | 65 (41%) | 101 (41%) | 0.93 | 41 (42%) | 100 (42%) | 0.16 |
COPD | 25 (16%) | 31 (12%) | 0.29 | 16 (16%) | 26 (11%) | 0.16 |
Cancer | 56 (35%) | 88 (35%) | 0.99 | 74 (76%) | 40 (17%) | 0.07 |
Diabetes mellitus | 39 (25%) | 68 (27%) | 0.60 | 22 (23%) | 72 (30%) | 0.18 |
Chronic cardiac failure | 36 (23%) | 33 (13%) | 0.01 | 20 (21%) | 34 (14%) | 0.15 |
Chronic renal failure | 20 (13%) | 33 (13%) | 0.94 | 17 (18%) | 26 (11%) | 0.09 |
Immunodepression | 43 (27%) | 77 (31%) | 0.46 | 29 (30%) | 64 (27%) | 0.55 |
Fluid expansion | 500 [500–1000] | 750 [500–1250] | < 10–3 | 750 [500–1200] | 750 [500–1025] | 0.71 |
Catecholamine | 25 (16%) | 77 (31%) | 0.001 | 29 (30%) | 62 (26%) | 0.45 |
Antibiotic therapy | 35 (22%) | 80 32%) | 0.03 | 25 (26%) | 77 (32%) | 0.26 |
Prehospital duration | 56 ± 30 | 70 ± 31 | < 10–3 | 60 ± 30 | 66 ± 32 | 0.50 |
Hospital LOS | 11 [6-21] | 12 [7-20] | 0.27 | 6 [2-12] | 15 [9-23] | < 10–3 |